Global Gamma Knife System Market Size By Type (Head Gamma Knife System, Body Gamma Knife System), By Application (Brain Metastasis, Cancer), By Region, And Segment Forecasts, 2023 to 2032

lobal Gamma Knife System Market Report Description

The Global Gamma Knife System Market was valued at USD 563 million in 2023 and is expected to reach USD 942 million by 2031, expanding at a CAGR of 6.7% during the forecast period from 2023 to 2031. Gamma Knife systems are advanced radiosurgical tools used for non-invasive treatment of brain disorders, such as brain tumors, arteriovenous malformations (AVMs), and functional disorders like trigeminal neuralgia. The increasing incidence of neurological disorders, growing preference for minimally invasive procedures, and rising investments in advanced healthcare infrastructure are driving market growth globally.

Drivers:

1. Rising Incidence of Neurological Disorders:

Globally, neurological conditions such as brain tumors and AVMs are on the rise. Gamma Knife procedures offer a targeted treatment option with minimal side effects, supporting their adoption among healthcare providers.

2. Preference for Non-Invasive Procedures:

Patients and physicians alike are turning to minimally invasive treatments due to lower recovery times, reduced hospital stays, and fewer post-operative complications. Gamma Knife systems cater directly to this demand.

3. Technological Advancements in Radiosurgery:

The integration of imaging modalities like MRI and CT with Gamma Knife systems is improving the accuracy and efficiency of treatments, boosting their appeal in modern neurosurgical centers.

Restraints:

1. High Equipment and Maintenance Costs:

The initial capital investment and ongoing maintenance for Gamma Knife systems are substantial, limiting their deployment primarily to large hospitals and specialty centers.

2. Limited Accessibility in Developing Regions:

In low- and middle-income countries, the lack of financial and technical resources hinders the adoption of Gamma Knife systems, constraining market expansion.

Opportunity:

1. Growing Investments in Specialty Clinics and Neurosurgery Centers:

As healthcare systems across the globe expand their neurosurgical capabilities, there is increasing demand for high-precision radiosurgical tools, opening new opportunities for Gamma Knife system manufacturers.

2. Expanding Application in Functional Neurosurgery:

Beyond oncology, Gamma Knife technology is being applied in functional neurosurgery for conditions such as epilepsy and obsessive-compulsive disorder (OCD), further broadening its market potential.

Market by System Type Insights:

By system type, the Perfexion model accounted for the largest market share in 2023 due to its broad clinical capabilities and efficiency in treating multiple targets simultaneously. However, the ICON model is expected to witness the fastest growth, attributed to its integrated imaging system and flexible treatment planning options.

Market by End-use Insights:

Hospitals and Specialized Neurosurgical Centers represented the dominant end-use segment in 2023, holding over 60% of the market share. These institutions are best equipped to afford and utilize advanced Gamma Knife systems due to their infrastructure, staffing, and patient volume. The ambulatory surgery centers segment is anticipated to gain traction due to the shift toward outpatient treatment formats in developed countries.

Market by Regional Insights:

North America led the global Gamma Knife System Market in 2023, driven by well-established healthcare infrastructure, a high number of neurosurgical procedures, and strong presence of key market players. Meanwhile, Asia-Pacific is expected to exhibit the highest CAGR during the forecast period, spurred by rising healthcare investments, growing awareness of radiosurgery, and increasing prevalence of neurological disorders in countries like China, India, and Japan.

Competitive Scenario:

Leading companies in the Gamma Knife System Market include Elekta AB, Varian Medical Systems, Accuray Incorporated, GE Healthcare, and Siemens Healthineers. These firms are investing in R&D to enhance precision, reduce treatment times, and expand indications for Gamma Knife systems. Key strategies include partnerships with hospitals, product launches, and geographic expansion.

Key Market Developments:

2023: Elekta introduced AI-powered planning software to enhance precision and reduce planning time for Gamma Knife radiosurgery.

2024: GE Healthcare collaborated with tertiary hospitals in India to install integrated MRI-compatible Gamma Knife systems.

2025: Varian Medical Systems acquired a European start-up specializing in functional radiosurgery software to diversify its treatment planning tools.

Scope of Work – Global Gamma Knife System Market

Report Metric Details

Market Size (2023) USD 563 million

Projected Market Size (2031) USD 942 million

CAGR (2023–2031) 6.7%

Market Segments By System Type (Perfexion, ICON), End-use, Region

Growth Drivers Increasing neurological disorders, preference for non-invasive procedures, tech innovation

Opportunities Expansion into functional neurosurgery, growth in specialty clinics

FAQs:

1. What is the current market size of the Global Gamma Knife System Market?

The Global Gamma Knife System Market was valued at USD 563 million in 2023.

2. What is the major growth driver of the Global Gamma Knife System Market?

The major growth drivers include the rising incidence of neurological disorders and increasing preference for non-invasive neurosurgical procedures.

3. Which is the largest region during the forecast period in the Global Gamma Knife System Market?

North America holds the largest market share due to advanced healthcare infrastructure and high adoption of radiosurgery.

4. Which segment accounted for the largest market share in the Global Gamma Knife System Market?

The Perfexion model dominated the system type segment in 2023.

5. Who are the key market players in the Global Gamma Knife System Market?

Key players include Elekta AB, Varian Medical Systems, GE Healthcare, Accuray Incorporated, and Siemens Healthineers.